Oxidative stress-related parameters and antioxidant status in non-alcoholic fatty liver disease patients

Iranian Journal of Endocrinology and Metabolism

Volumn 12, Issue 5, 2011, Pages

  Orangi, E ^a   Ostad Rahimi, A ^b   Mahdavi, R ^b   Somi, M ^a   Tarzemani, M ^b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Malondialdehyde; Non alcoholic fatty liver (NAFLD); Obesity; Oxidative stress; Total antioxidant capacity

Indexed keywords

LIVER ENZYME; MALONALDEHYDE;

ANTIOXIDANT ACTIVITY; ARTICLE; BODY MASS; CHI SQUARE DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FATTY LIVER; HUMAN; LIVER CIRRHOSIS; LIVER FIBROSIS; NONALCOHOLIC FATTY LIVER; OBESITY; OXIDATIVE STRESS; STUDENT T TEST;

EID: 79551539903     PISSN: 16834844     EISSN: 16835476     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980; 55: 434-8.
2. Falck-Yetter Y, Younossi ZM, Marchesini G, McCullough AJ. Clinical features and natural history of nonalcoholic steatosis syndromes.Semin Liver Dis 2001; 21: 17-26.
3. Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: an expanded clinical entity.Gastroenterology 1994; 107: 1103-9.
4. McCullough AJ. Update on nonalcoholic fatty liver disease. J Clin Gastroenterol 2002; 34; 255-62.
5. Zetterman RK. Fatty liver in disease of the liver. eight edition. Lipincott Williams wilkins 1999; 68-75.
6. Bonkovsky HL. Optimal management of nonalcoholic fatty liver/steatohepatitis. J Clin Gastroenterol 2003; 36: 193-5.
7. Marchesini G, Briz M, Morselli-Labate AM, Bianchi G, Bugianesi E, McCullough AJ, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999; 107: 450-5.
8. Sies H. Oxidative stress: introductory remarks. Oxidative stress, edited by Sie H. New York: Academic 1985; p 1-8.
9. Videla LA, Rodrigo R, Orellana M, Fernandez V, Tapia G, Quinones L, et al. Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients. Clin Sci (Lond) 2004; 106: 261-8.
10. Madan K, Bhardwaj P, Thareja S, Gupta SD, Saraya A. Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD). J Clin Gastroenterol 2006; 40: 930-5.
11. Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, et al. Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001; 120: 1183-92.
12. Bonnefont-Rousselot D, Ratziu V, Giral P, Charlottes F, Beucler I, Poynard T. Blood oxidative stress markers are unreliable markers of hepatic steatosis. Aliment Phamacol Ther 2005; 23: 91-8.
13. Toshimitsu K, Matsuura B, Ohkubo I, Niiya T, Furukawa S, Hiasa T, et al. Dietary habits and nutrient intake in non-alcoholic steatohepatitis. Nutrition 2007; 23: 46-52.
14. Bahrami H, Daryani NE, Mirmomen S, Kamangar F, Haghpanah B, Djalili M. Clinical and histological features of nonalcoholic steatohepatitis in Iranian patients. BMC Gastroenterol 2003; 3-27.
15. Pourshams A, Malekzadeh A, Monavvari A, Akbari MR, MohamadKhani A, Yarahmadi S, et al. Prevalence and etiology of persistently elevated alanine aminotransferase levels in healthy Iranian blood donors. J Gastroenterol and Hepatol 2005; 20: 229-33.
16. Allard JP, Aghdassi E, Mohammed S, Raman M, Avand G, Arendt BM, et al. Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD):A cross-sectional study. J Hepatol 2008; 48: 300-7.
17. Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: A follow-up study of forty-two patients follow for up to 21 years. Hepatology 1990; 11: 74-80.
18. Mccullough AJ. update on nonalcoholic steatohepatitis. J Clin Gastroenterol 2002; 34; 255-62.
19. Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with an analysis of risk factors. Hepatology 1990; 12: 1106-10.
20. Demeo MT, Mobarhan S, Mikolaitis S, Kazi N. Three cases of comprehensive dietary therapy and pharmacotherapy of patient with complex obesity related disease. Nutr Rev 1997; 55: 297-302.
21. Patrick L. Nonalcoholic fatty liver disease: relationship to insulin sensitivity and oxidative stress. Treatment approaches using vitamin E, magnesium, and betaine. Altern Med Rev 2002; 7: 276-91.
22. Sreekumar R, Rosado B, Rasmussen D, Charlton M. Hepatic gene expression in histologically progressive nonalcoholic steatohepatitis. Hepatology 2003; 38: 244-51.
23. Yesilova Z, Yaman H, Oketenli C, Ozcan A, Uygun A, Cakir E, et al. Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic Fatty liver disease. Am J Gastroenterol 2005; 100: 850-5.
24. Malaguarnera L, Madeddu R, Palio E, Arena N, Malaguarnera M. Heme oxygenase-1 levels and oxid-ative stress-related parameters in nonalcoholic fatty liver disease patients. J Hepatol 2005; 42: 585-91.
25. Loguercio C, De Girolamo V, de Sio I, Tuccillo C, Ascione A, Baldi F. Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects.J Hepatol 2001; 35: 568-74.
26. Perlemuter G, Davit-Spraul A, Cosson C, Conti M, Bigorgne A, Paradis V, et al. Increase in liver antioxidant enzyme activities in non-alcoholic fatty liver disease. Liver Int 2005; 25: 946-53.